A new computer program allows scientists to design synthetic DNA segments that indicate, in real time, the state of cells. Reported by the Gargiulo lab in “Nature Communications”, it will be used to screen for anti-cancer or viral infections drugs,…
Some hereditary genetic defects cause an exaggerated immune response that can be fatal. Using the CRISPR-Cas9 gene-editing tool, such defects can be corrected, thus normalizing the immune response, as researchers led by Klaus Rajewsky from the Max…
Researchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center have new findings on brain stiffness as a marker of neuroinflammation in multiple sclerosis to report. In this section, they answer questions about their research…
Erasmus Mundus joint master in Germany, France, and Slovenia
Cold, isolation, weightlessness: People face extreme conditions in places like Antarctica or space. Space medicine is the study of how humans adapt to these environments and how to…
Clinicians Recently Performed the 100,000th Procedure Implanting an ICD Equipped with DX Technology – the World’s Only Single-Lead ICD System Providing Direct Atrial Sensing
They offer hope for people who do not respond to conventional treatments or for whom there is no effective therapy yet available: advanced therapy medicinal products (ATMPs). The first of these novel medications, developed using genetic and cell…
The details of many immune defense mechanisms are still unknown, but a new study sheds light on one such mechanism. Writing in “The EMBO Journal”, researchers led by Oliver Daumke and Misha Kudryashev of the Max Delbrück Center describe exactly how…
Today, the European Commission is proposing more time for companies to apply the In Vitro Diagnostic Medical Devices Regulation (IVDR), under certain conditions. With this revision, the Commission aims to ensure patient care by improving the…
Chemistry on brink of complete transformation
Cell-based immunotherapies, particularly lab-produced immune cells known as CAR T cells, show promise in treating various cancers. But how do we produce effective ones? Gaetano Gargiulo from the Max Delbrück Center will develop a novel screening…
